Therapeutic Group: Urological Presentation Maturex 30 Tablet: Each tablet contains Dapoxetine Hydrochloride INN equivalent to Dapoxetine 30 mg. Maturex 60 Tablet: Each tablet contains Dapoxetine Hydrochloride INN equivalent to Dapoxetine 60 mg. Description Dapoxetine tablet belongs to the pharmacotherapeutic group of Selective Serotonin Reuptake Inhibitors (SSRIs). The mechanism of action of dapoxetine in premature ejaculation […]
Therapeutic Group: Sodium-glucose Co-transporter 2 inhibitor Presentation Dapaglip TM 5: Each tablet contains Dapagliflozin Propanediol Monohydrate INN equivalent to Dapagliflozin 5 mg. Dapaglip TM 10: Each tablet contains Dapagliflozin Propanediol Monohydrate INN equivalent to Dapagliflozin 10 mg. Description Dapagliflozin is an inhibitor of Sodium-Glucose Cotransporter 2 (SGLT2). By inhibiting SGLT2, Dapagliflozin reduces reabsorption of filtered […]
Therapeutic Group: Skeletal Muscle Relaxant Presentation Danlene Capsule: Each capsule contains Dantrolene Sodium USP 25 mg. Description Dantrolene produce relaxation by affecting the contractile response of the skeletal muscle. In skeletal muscle, Dantrolene dissociates the excitation-contraction coupling, probably by interfering with the release of Ca++ from the sarcoplasmic reticulum. Indications In Chronic Spasticity: Dantrolene is […]
Therapeutic Group: Gynaecological Presentation Lozana 100: Each capsule contains Danazol USP 100 mg. Lozana 200: Each capsule contains Danazol USP 200 mg. Description Lozana is a weak impeded androgen with associated anabolic properties. It inhibits gonadotropin-releasing hormone and gonadotropin secretion. This suppresses menstruation, inhibits ovulation, and causes regressive change in the vaginal smear and atrophic […]
Therapeutic Group: Anti Cancer Presentation Dacocent 45: Each film coated tablet contains Dacomitinib Monohydrate INN equivalent to Dacomitinib 45 mg. Description Dacomitinib is an irreversible inhibitor of the kinase activity of the human EGFR family (EGFR/HER1, HER2, and HER4)and certain EGFR activating mutations (exon 19 deletion or the exon 21 L858R substitution mutation). In vitro […]
Therapeutic Group: Anti Viral, Hepatitis C Medication Presentation Each Tablet contains Daclatasvir Dihydrochloride INN equivalent to Daclatasvir 60 mg. Description Daclatasvir is a potent and specific inhibitor of the HCV NS5A replication complex. The HCV NS5A is a multifunctional protein with key functions in HCV replication and modulation of cellular signaling pathways. Indications Daclatasvir is […]
Therapeutic Group: Ophthalmic- Immunosuppressant Presentation Sporium Max Sterile Ophthalmic Solution: Each ml contains Cyclosporine USP 0.9 mg. Description SporiumMax Sterile Ophthalmic Solution is a preparation of Cyclosporine 0.09% which acts as immunomodulator in patients whose tear production is suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Indications This drug is indicated to increase tear […]
Therapeutic Group: Immunosuppresant Presentation Sporium solution: Each ml solution contains Cyclosporine USP 100 mg. Description Cyclosporine is a cyclic polypeptide consisting of 11 amino acids. It is a potent immunosuppressive agent, which prolongs survival of allogeneic transplants of skin, heart, kidney, pancreas, bone marrow, small intestine or lung. Cyclosporine acts specifically and reversibly on lymphocytes. […]
Therapeutic Group: Skeletal Muscle Relaxant Presentation Flexor 5: Each tablet contains Cyclobenzaprine Hydrochloride USP 5 mg. Flexor 10: Each tablet contains Cyclobenzaprine Hydrochloride USP 10 mg. Description Cyclobenzaprine Hydrochloride relieves skeletal muscle spasm of local origin without interfering with muscle function. Indications Flexor is indicated as an adjunct to rest and physical therapy for relief […]
Therapeutic Group: Oncology Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including ALK, Hepatocyte Growth Factor Receptor (HGFR, c-Met), ROS1 (c-ros), and Recepteur d’Origine Nantais (RON). Translocations can affect the ALK gene resulting in the expression of oncogenic fusion proteins. The formation of ALK […]